Ventria Bioscience And The Controversy

The cultivation of rice has had an enormous impact on the natural biome. Rice has affected the natural biome that it is grown in, in a devastating way. It has caused the natural biomes to deteriorate and caused the natural way of life to collapse leaving no place for the native animals and plants. But what would happen if the cultivation of rice stopped and the natural biomes returned to their former glory? What would happen to all those people depending on rice for the next meal? Those who depend on rice to pay for and keep their families alive? This report looks at the where, effects, who and how of rice cultivation.

With the level of technology at where it is today there are many risks involved with many treatments. What the companies tend to do is advertise products and try to make the risks seem small. Every time you watch TV nowadays there is a commercial on there about a treatment that has

High capital expenditure into research and development, lengthy approval process, marketing before any realized returns are a major deterrent for any new entrant. It is a highly regulated industry. Also, the presence of “big pharma” companies deters new competitors.

Those target markets who rely on Johnson & Johnson health and medical needs are mostly patients, doctors, nurses and civilians. Therefore, the company need to sustain their products and services over all these years to ensure that lower income people and underprivileged patients are able to access on their medicines. This however requires the company to balance patient’s access and competitive dynamics in line with their need as the company need to have enough resources to keep on being innovating, creating new and better medicines and at the same time making sure there will be a fair return to the shareholder as well. Johnson & Johnson also work closely with the governments, physicians, non-government organizations and the international donors all around the world to provide its products within an affordable prices to its

4. Who are the stakeholders in this situation and what, if any, obligations do they have?

The second rests in Pfizer’s expiring patents on several popular drugs that invite their competitors to enter the market with similarly performing pharmaceuticals. Once these patents expire, Pfizer will either have to extend the patent through reformulating the performance of the drug for another purpose called “ever greening”, or abandon the line in the pursuit of another, more profitable product. Regardless of what they do in terms of their own product offerings, generic imitations of their products will enter the market, diluting the profitability of the drug and forcing reliance on the sales of other existing products to make up the loss.

In this paper I am writing on the Ventria Bioscience and the Controversy over Plant-Made Medicines Case. Ventria Bioscience is a company that is trying to commercialize pharmaceuticals made from genetically modified plants. While Ventria is gaining opposition from regulators, activist, and environmentalist; they could succeed if they use their relevant stakeholders and specific strategies, information, financial incentive, constituency building, to influence regulators.

he problem that is facing Scott Deeter and Ventria are the critics. Scott Deeter wants to expand Ventria, and allow rice to be grown with man-made medicine. There have been many discussions following this issue. Mostly that the rice will contaminate the rice intended for human food, among animal food. There also are comments regarding to the environment and that doing things like this will cause harm. Not to mention, all the ethical dilemmas that go along with it. Scott Deeter has come back with a plan for every argument the critics have thrown at him, but that still is not enough. No matter what he says, or does, people will still not support his plan to do this. This situation is very similar to when you are arguing with someone who always

In this case for me one of the company's problem is the low income to their company which must solve the problem of management to have a good image of the company concerned. Cheap Pharma provides a way to reach them have a big income due to gradual collapse of their sales as a result desired by Mr. de Guzman and the other two board of directors agreed to buy shares of stocks of Green Med where it has the boost to help build a unique products that can provide big profits for their company.

I think that there are a few options that might emerge from this dialogue. Some of which, that the California Rice Industry would be more apt to let Ventria grow the rice if they took the proper precautions to prevent the accidental spread and germination of the genetically altered rice. The stakeholders may make Ventria change their protocol to make it stricter to ensure that there is no possible way that they will cross-contaminate any other food sources. The stakeholders want to be absolutely sure that with the work Ventria is doing, that no lives and food resources will be lost.

2. What is your assessment of the pharmaceutical industry at the time of the case? How is competition changing? What factors are driving

Ventria has a huge opportunity to create relationships to farmers and consumers in the next years and to contribute to communities around their farms and especially the government. Ventria should continue to consider and experiment with different ideas and ways that will not only be approved by the FDA, but can portray the benefits to environmentalists, food safety activists, consumer advocates. The company regulations, goals and values allow them to ensure this by following all rules and regulations and addressing and acknowledging any potential problem in their attempt to achieve their bioscience organization goals. Scott Deeter does a phenomenal job of this by speaking for the less fortunate and his passion for his company. Ventria will achieve their long terms company goals by working closely with all government agencies concerned, especially California Rice Commission. They will continue to seek stakeholder’s investments, continue research studies and stress to the public and the actual benefits of their rice product through testing. Stakeholders, Investors, Board members, Government (includes FDA, APHIS, USDA), CRC (CA Rice Commission), Scientists, and Environmentalists are all groups that have a stake in Ventria’s actions. All have interests and power regarding the plant made medicines and Ventria’s decisions. A political argument might be that government would have the most power, however APHIS has yet to approve

Threats—Very competitive market Viagra already the brand name with a 5 year head start on safety and reliability, Pfizer has the largest sales force, Bayer’s niche ability to address the issues of diabetics, competitors very large R&D budget and Pfizer $108 million advertising budget, increased competition

In 2000, Merck began to cooperate with Schering-Plough on several research products and in 2009 acquired their longtime partner in an effort to diversify its products and reach a broader consumer base. With challenges that include rising prices of research and prescription drugs, Merck has managed to forge forward and overcome obstacles. Merck’s survival has been a subject of speculation many times throughout the years; from the 2004 recall of their top selling drug (Vioxx) due to undesirable side effects to the recently curtailed trials of their very promising new anti-clotting drug (Vorapaxar) due to negative trial results. Kenneth Frazier, Merck’ CEO, has also come under heavy criticism due to his unconventional decision not to cut research budgets in order to increase profits. This strategy differs greatly from the usual path and it has cost Merck investor confidence which resulted in lowered stock prices . Although Merck has been subjected to challenges throughout their history they have always managed to stay afloat and maintain their reputation as a leader in healthcare.

According to Evenson the top three threats are, “increase in competition in the international market; the growing competition with other economic activities that increases the cost of production, especially the labor cost; and degradation of ecological conditions. Rice production around the world has become more competitive. This makes it harder for Thailand to keep its competitive advantage with its Jasmine rice. As for the modernization of the nation, it has lead to an increase cost of labor. This makes it more expensive for rice farmers that used to use cheap manual labor. Finally the massive amount of land used for the production of rice may have long term negative affects on the yields of the land. (Evenson)